June 2022

Thyme Care: A Human Touch in Cancer Care, Guided by Technology

June 23, 2022

IVBM COVERAGE

Oncologist and health tech veteran Bobby Green, MD, who practiced for 17 years in Florida and was previously with Flatiron, is now Thyme Care’s president and chief medical officer. He has relocated to Nashville, Tennessee, to launch Thyme Care.

Bringing Innovation to Value-Based Care at Scale, With an Assist From Technology

June 23, 2022

IVBM COVERAGE

The Institute of Value-Based Medicine® (IVBM), hosted by Tennessee Oncology, brought health care leaders together on April 21 in Nashville, Tennessee, to discuss oncology care delivery—and to see colleagues in person, some for the first time since 2020.

COTA’s Miruna Sasu on Real-world Evidence: “The Ecosystem Has Changed”

June 23, 2022

Miruna Sasu, PhD, MBA, became president and CEO of COTA Healthcare in March 2022, not quite a year after joining the company as its chief strategy officer. As the importance of RWD grows, Sasu is ready to take its use in precision oncology to new levels. She spoke with Evidence-Based Oncology™ (EBO) about her new role.

Adding Drug Costs to the Clinical Support Equation

June 23, 2022

COVER FEATURE

Amy Valley, PharmD, vice president of clinical strategy and technology solutions, Cardinal Health Specialty Solutions, discusses the Decision Path, a clinical support tool designed to inform oncology providers about drug costs along with clinical information, all embedded into the electronic health record workflow.

Value-Based Care Will “Continue to Evolve” Even if OCM Expires

June 23, 2022

COVER FEATURE

Four experts from The US Oncology Network partnered with The American Journal of Managed Care® to present a webinar, “Beyond the OCM: How Are Commercial Payers & Employers Delivering Value-Based Cancer Care?”

Crowdfunding for Cancer: What Financial Toxicity Among Young Adults Says About the US Health Care System

May 02, 2022

COVER FEATURE

Although crowdfunding can be a financial lifeline for young adult patients with serious medical conditions, the nuances regarding the need for and the long-term impact of crowdfunding exposes a facet of the US health care system that must be addressed.